FY2026 EPS Estimates for McKesson Boosted by Zacks Research

McKesson Corporation (NYSE:MCK) – Equities researchers at Zacks Research lifted their FY2026 EPS estimates for McKesson in a research report issued to clients and investors on Tuesday, June 17th. Zacks Research analyst R. Department now expects that the company will earn $36.87 per share for the year, up from their previous estimate of $36.77. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Zacks Research also issued estimates for McKesson’s Q4 2026 earnings at $10.52 EPS, Q1 2027 earnings at $9.96 EPS, Q2 2027 earnings at $9.63 EPS, FY2027 earnings at $41.61 EPS and FY2028 earnings at $46.38 EPS.

A number of other analysts have also recently issued reports on MCK. Wall Street Zen cut shares of McKesson from a “strong-buy” rating to a “buy” rating in a research note on Saturday, June 14th. Wells Fargo & Company set a $766.00 target price on shares of McKesson and gave the stock an “equal weight” rating in a research note on Tuesday, June 3rd. Bank of America raised their target price on shares of McKesson from $755.00 to $800.00 and gave the stock a “buy” rating in a research note on Friday, May 9th. Cfra Research cut shares of McKesson from a “moderate buy” rating to a “hold” rating in a research note on Friday, April 4th. Finally, Mizuho raised their price target on shares of McKesson from $630.00 to $690.00 and gave the stock a “neutral” rating in a research report on Thursday, April 3rd. Three equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $694.38.

McKesson Price Performance

Shares of MCK stock opened at $729.28 on Thursday. The stock has a market cap of $91.24 billion, a P/E ratio of 28.23, a P/E/G ratio of 1.46 and a beta of 0.49. The company has a fifty day moving average price of $707.81 and a two-hundred day moving average price of $647.13. McKesson has a one year low of $464.42 and a one year high of $732.99.

McKesson (NYSE:MCK) last announced its quarterly earnings results on Thursday, May 8th. The company reported $10.12 EPS for the quarter, beating analysts’ consensus estimates of $9.83 by $0.29. The firm had revenue of $90.82 billion during the quarter, compared to analysts’ expectations of $94 billion. McKesson had a net margin of 0.92% and a negative return on equity of 201.12%. The company’s revenue for the quarter was up 18.9% compared to the same quarter last year. During the same quarter last year, the company posted $6.18 earnings per share.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be paid a dividend of $0.71 per share. The ex-dividend date is Monday, June 2nd. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.39%. McKesson’s payout ratio is presently 10.99%.

Insiders Place Their Bets

In other news, CEO Brian S. Tyler sold 19,370 shares of McKesson stock in a transaction on Friday, June 6th. The shares were sold at an average price of $705.93, for a total transaction of $13,673,864.10. Following the transaction, the chief executive officer now owns 51,243 shares in the company, valued at approximately $36,173,970.99. The trade was a 27.43% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Britt J. Vitalone sold 6,336 shares of McKesson stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $717.30, for a total transaction of $4,544,812.80. Following the transaction, the chief financial officer now owns 14,760 shares in the company, valued at approximately $10,587,348. This trade represents a 30.03% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,117 shares of company stock valued at $23,526,451. 0.11% of the stock is currently owned by insiders.

Hedge Funds Weigh In On McKesson

Hedge funds have recently modified their holdings of the business. Dynamic Advisor Solutions LLC lifted its holdings in shares of McKesson by 16.6% during the first quarter. Dynamic Advisor Solutions LLC now owns 778 shares of the company’s stock worth $524,000 after purchasing an additional 111 shares during the period. Wealth Enhancement Advisory Services LLC lifted its holdings in McKesson by 4.3% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 183,258 shares of the company’s stock valued at $123,332,000 after buying an additional 7,556 shares during the period. Segall Bryant & Hamill LLC lifted its holdings in McKesson by 25.5% in the fourth quarter. Segall Bryant & Hamill LLC now owns 81,223 shares of the company’s stock valued at $46,290,000 after buying an additional 16,502 shares during the period. Fred Alger Management LLC lifted its holdings in McKesson by 95.5% in the fourth quarter. Fred Alger Management LLC now owns 3,091 shares of the company’s stock valued at $1,762,000 after buying an additional 1,510 shares during the period. Finally, Siemens Fonds Invest GmbH lifted its holdings in McKesson by 623.3% in the fourth quarter. Siemens Fonds Invest GmbH now owns 31,470 shares of the company’s stock valued at $17,935,000 after buying an additional 27,119 shares during the period. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.